AFFX Profile
Affymetrix, Inc. (AFFX) is a biotechnology company based in Santa Clara, California, USA. The company is primarily engaged in developing and manufacturing products for genetic analysis, including gene expression and genotyping analysis systems, as well as providing services for genetic research and analysis.
Affymetrix's primary products include GeneChip microarrays, which allow for high-throughput analysis of genetic data, and GeneTitan instruments, which automate genetic analysis processes. The company also offers a range of services for genetic research and analysis, including genotyping and gene expression analysis services, as well as bioinformatics support.
Affymetrix was a subsidiary of Thermo Fisher Scientific, Inc., a global biotechnology company that acquired Affymetrix in 2016. Prior to the acquisition, Affymetrix was a publicly traded company on the NASDAQ stock exchange under the ticker symbol AFFX.
In terms of financial performance, Affymetrix reported revenues of approximately $340 million and net income of approximately $1 million in the year ended December 31, 2015. However, as mentioned earlier, this information may be outdated due to the acquisition by Thermo Fisher Scientific.
|
